These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4945790)

  • 21. [Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
    Zemelman R; González C; Mondaca MA
    Rev Med Chil; 1980 Dec; 108(12):1112-7. PubMed ID: 7302408
    [No Abstract]   [Full Text] [Related]  

  • 22. Rifampicin in the treatment of resistant pulmonary tuberculosis.
    Wäre M; Lorenzen J
    Scand J Respir Dis Suppl; 1970; 72():113-9. PubMed ID: 4990617
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
    Grumbach F; Rist N
    Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
    [No Abstract]   [Full Text] [Related]  

  • 24. [Malformations caused by rifampicin? 2 cases of normal fetal development after rifampicin treatment in early pregnancy].
    Reimers D
    Munch Med Wochenschr; 1971 Dec; 113(50):1690-1. PubMed ID: 5171622
    [No Abstract]   [Full Text] [Related]  

  • 25. Toxicologic and pharmacologic aspects of rifampin.
    Radner DB
    Chest; 1973 Aug; 64(2):213-6. PubMed ID: 4199024
    [No Abstract]   [Full Text] [Related]  

  • 26. The nonprophylactic role of cephalosporins in obstetrics and gynecology.
    LeFrock JL; Smith BR; Molavi A
    Bull N Y Acad Med; 1984 May; 60(4):416-25. PubMed ID: 6372917
    [No Abstract]   [Full Text] [Related]  

  • 27. Rifampicin-susceptibility and rifampicin-resistance in mycobacteria.
    Manten A; van Wijngaarden LJ; van Klingeren B
    Acta Tuberc Pneumol Belg; 1969; 60(3):329-34. PubMed ID: 4984415
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapy of experimental staphylococcal mastitis in the mouse with cloxacillin and rifampicin, alone and in combination.
    Craven N; Anderson JC
    Res Vet Sci; 1981 Nov; 31(3):295-300. PubMed ID: 6919178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifampicin desacetylation in the human organism.
    Maggi N; Furesz S; Pallanza R; Pelizza G
    Arzneimittelforschung; 1969 Apr; 19(4):651-4. PubMed ID: 5819167
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of rifampicin (rifamycin AMP) on the fetus].
    Sakagami M; Fujimoto K
    Jpn J Antibiot; 1970 Dec; 23(5):454-63. PubMed ID: 5313863
    [No Abstract]   [Full Text] [Related]  

  • 31. Actions of the rifamycins.
    Wehrli W; Staehelin M
    Bacteriol Rev; 1971 Sep; 35(3):290-309. PubMed ID: 5001420
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experiences with new tuberculostatics in the treatment of urogenital tuberculosis (capreomycin, ethambutol, rifampicin)].
    May P; König K
    Z Urol Nephrol; 1969; 62(9):657-62. PubMed ID: 5408556
    [No Abstract]   [Full Text] [Related]  

  • 33. [Animal experimental studies on the effect of rifampicin on pathogenic gas gangrene bacilli].
    Schallehn G
    Schweiz Med Wochenschr; 1969 Jul; 99(29):1057-9. PubMed ID: 5802010
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of clinical effect between rifampicin and aminobenzylpenicillin in urinary tract infections by double blind method].
    Narahashi K; Momose S
    Hinyokika Kiyo; 1970 Dec; 16(12):781-6. PubMed ID: 4925066
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vitro sensitivity of Staphylococcus and gram negative bacteria to rifampicin].
    Ales Reinlein AM; Fernández Puentes MC; Torres Cid A
    Rev Clin Esp; 1973 Jul; 130(2):99-102. PubMed ID: 4742347
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibiotics and chemotherapeutic agents--from research to practice. II. Remarks for the practitioner on the characteristics of tetracyclines].
    Pilloud M
    Schweiz Arch Tierheilkd; 1982 Apr; 124(4):179-88. PubMed ID: 7048522
    [No Abstract]   [Full Text] [Related]  

  • 37. Rifampin: antibacterial activity in vitro and absorption and excretion in normal young men.
    Dans PE; McGehee RF; Wilcox C; Finland M
    Am J Med Sci; 1970 Feb; 259(2):120-32. PubMed ID: 4984031
    [No Abstract]   [Full Text] [Related]  

  • 38. [A new antitubercular agent: rifampicin].
    Favez G
    Schweiz Rundsch Med Prax; 1970 Feb; 59(8):296-7. PubMed ID: 4996719
    [No Abstract]   [Full Text] [Related]  

  • 39. Local diffusibility of rifampicin in tuberculous lesions of bone and joint.
    Popescu E; Algeorge G; Paunescu E; Stoinescu M; Rudescu D
    Respiration; 1971; 28():Suppl:44-51. PubMed ID: 5150795
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental study of rifampicin and ethambutol].
    Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1971; 49(1):64-8. PubMed ID: 5576515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.